Millions of women taking semaglutide or similar GLP-1 receptor agonists for diabetes and obesity now have a new data point to ...

Erica Boran tells PEOPLE about her weight-loss journey and getting plastic surgery ...

Add Yahoo as a preferred source to see more of our stories on Google. Obesity is a known risk factor for breast cancer, so could some women reduce their odds of this common type of cancer by taking ...

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the ...

A trio of large observational studies reported at the San Antonio Breast Cancer Symposium (SABCS) 2025 suggest that GLP-1 receptor agonists may improve outcomes in some women with breast cancer. Two ...

Learn why timing and muscle health are vital when using GLP-1 therapy for weight management during and after breast cancer treatment. For many individuals diagnosed with breast cancer, the journey ...

Add Yahoo as a preferred source to see more of our stories on Google. In a town full of phonies, Sophia Umansky isn’t afraid to be herself. The influencer openly documented going under the knife for a ...

GLP-1 drugs like Wegovy and Zepbound have transformed the landscape of weight loss and been shown to reduce risk of diabetes and cravings for alcohol. Now, new research suggests that they also may ...

Obesity is a known risk factor for breast cancer, so could some women reduce their odds of this common type of cancer by taking weight-loss drugs such as Wegovy and Zepbound? A study of more than ...